Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis

Paul J. Hengeveld; Hendrik Veelken; Cornelis A. M. van Bergen; Edwin Quinten; Mischa Y. L. Vervoordeldonk; Wahija Ismailzada; Rob S. Barendse; Julie M. N. Dubois; Marinus H. J. van Oers; Christian H. Geisler; Arnon P. Kater; Peter E. Westerweel; Anton W. Langerak; Mark-David Levin

doi:https://doi.org/10.1038/s41375-023-01975-0

Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis

Paul J. Hengeveld, Hendrik Veelken, Cornelis A. M. van Bergen, Edwin Quinten, Mischa Y. L. Vervoordeldonk, Wahija Ismailzada, Rob S. Barendse, Julie M. N. Dubois, Marinus H. J. van Oers, Christian H. Geisler, Arnon P. Kater, Peter E. Westerweel, Anton W. Langerak, Mark-David Levin

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	1929-1932
Number of pages	4
Journal	Leukemia
Volume	37
Issue number	9
Early online date	2023
DOIs	https://doi.org/10.1038/s41375-023-01975-0
Publication status	Published - Sept 2023

Access to Document

https://doi.org/10.1038/s41375-023-01975-0

Cite this

Hengeveld, P. J., Veelken, H., van Bergen, C. A. M., Quinten, E., Vervoordeldonk, M. Y. L., Ismailzada, W., Barendse, R. S., Dubois, J. M. N., van Oers, M. H. J., Geisler, C. H., Kater, A. P., Westerweel, P. E., Langerak, A. W., & Levin, M.-D. (2023). Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis. Leukemia, 37(9), 1929-1932. https://doi.org/10.1038/s41375-023-01975-0

@article{4f8f01a470a24da8a3af418fcc451d28,

title = "Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis",

author = "Hengeveld, {Paul J.} and Hendrik Veelken and {van Bergen}, {Cornelis A. M.} and Edwin Quinten and Vervoordeldonk, {Mischa Y. L.} and Wahija Ismailzada and Barendse, {Rob S.} and Dubois, {Julie M. N.} and {van Oers}, {Marinus H. J.} and Geisler, {Christian H.} and Kater, {Arnon P.} and Westerweel, {Peter E.} and Langerak, {Anton W.} and Mark-David Levin",

note = "Funding Information: The authors would like to thank all patients, physicians and investigators who participated in the LUMC biobank, the AMC biobank for B cell malignancies and the HOVON-68 trial.",

year = "2023",

month = sep,

doi = "https://doi.org/10.1038/s41375-023-01975-0",

language = "English",

volume = "37",

pages = "1929--1932",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "9",

}

Hengeveld, PJ, Veelken, H, van Bergen, CAM, Quinten, E, Vervoordeldonk, MYL, Ismailzada, W, Barendse, RS, Dubois, JMN, van Oers, MHJ, Geisler, CH, Kater, AP, Westerweel, PE, Langerak, AW & Levin, M-D 2023, 'Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis', Leukemia, vol. 37, no. 9, pp. 1929-1932. https://doi.org/10.1038/s41375-023-01975-0

TY - JOUR

T1 - Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis

AU - Hengeveld, Paul J.

AU - Veelken, Hendrik

AU - van Bergen, Cornelis A. M.

AU - Quinten, Edwin

AU - Vervoordeldonk, Mischa Y. L.

AU - Ismailzada, Wahija

AU - Barendse, Rob S.

AU - Dubois, Julie M. N.

AU - van Oers, Marinus H. J.

AU - Geisler, Christian H.

AU - Kater, Arnon P.

AU - Westerweel, Peter E.

AU - Langerak, Anton W.

AU - Levin, Mark-David

N1 - Funding Information: The authors would like to thank all patients, physicians and investigators who participated in the LUMC biobank, the AMC biobank for B cell malignancies and the HOVON-68 trial.

PY - 2023/9

Y1 - 2023/9

UR - http://www.scopus.com/inward/record.url?scp=85165293126&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/s41375-023-01975-0

DO - https://doi.org/10.1038/s41375-023-01975-0

M3 - Comment/Letter to the editor

C2 - 37479761

SN - 0887-6924

VL - 37

SP - 1929

EP - 1932

JO - Leukemia

JF - Leukemia

IS - 9

ER -

Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis

Access to Document

Other files and links

Cite this